Terms: = Prostate cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
17 results:
1. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer.
Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ
Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167
[TBL] [Abstract] [Full Text] [Related]
2. Antitumor Activity of Small Activating RNAs Induced PAWR Gene Activation in Human Bladder cancer Cells.
Yang K; Shen J; Tan FQ; Zheng XY; Xie LP
Int J Med Sci; 2021; 18(13):3039-3049. PubMed ID: 34220332
[TBL] [Abstract] [Full Text] [Related]
3. Cystic metastasis of prostate cancer: A case report.
Zhang B; Bian B; Bi L; Wang Z; Zhao Y; Wang J
Medicine (Baltimore); 2018 Dec; 97(50):e13697. PubMed ID: 30558081
[TBL] [Abstract] [Full Text] [Related]
4. Skene's Glands Adenocarcinoma: A Series of 4 Cases.
Tregnago AC; Epstein JI
Am J Surg Pathol; 2018 Nov; 42(11):1513-1521. PubMed ID: 29901570
[TBL] [Abstract] [Full Text] [Related]
5. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection.
Gallan AJ; Antic T
Hum Pathol; 2016 Nov; 57():136-139. PubMed ID: 27438608
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
Yang K; Shen J; Chen SW; Qin J; Zheng XY; Xie LP
Oncol Rep; 2016 Apr; 35(4):2487-93. PubMed ID: 26797252
[TBL] [Abstract] [Full Text] [Related]
7. DNA vaccines, electroporation and their applications in cancer treatment.
Lee SH; Danishmalik SN; Sin JI
Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993
[TBL] [Abstract] [Full Text] [Related]
8. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells.
Casolari DA; Pereira MC; de Bessa Garcia SA; Nagai MA
Int J Mol Med; 2011 Sep; 28(3):337-42. PubMed ID: 21567071
[TBL] [Abstract] [Full Text] [Related]
9. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract] [Full Text] [Related]
10. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Köbel M; Kalloger SE; Boyd N; McKinney S; Mehl E; Palmer C; Leung S; Bowen NJ; Ionescu DN; Rajput A; Prentice LM; Miller D; Santos J; Swenerton K; Gilks CB; Huntsman D
PLoS Med; 2008 Dec; 5(12):e232. PubMed ID: 19053170
[TBL] [Abstract] [Full Text] [Related]
11. VEGF transcription and mRNA stability are altered by wt1 not DDS(R384W) expression in LNCaP cells.
Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G
Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect.
Sheffer Y; Leon O; Pinthus JH; Nagler A; Mor Y; Genin O; Iluz M; Kawada N; Yoshizato K; Pines M
Mol Cancer Ther; 2007 Feb; 6(2):570-7. PubMed ID: 17267660
[TBL] [Abstract] [Full Text] [Related]
13. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, wt1.
Hanson J; Gorman J; Reese J; Fraizer G
Front Biosci; 2007 Jan; 12():2279-90. PubMed ID: 17127464
[TBL] [Abstract] [Full Text] [Related]
14. Hormone treatment enhances wt1 activation of Renilla luciferase constructs in LNCaP cells.
Hanson J; Reese J; Gorman J; Cash J; Fraizer G
Front Biosci; 2007 Jan; 12():1387-94. PubMed ID: 17127389
[TBL] [Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) is suppressed in wt1-transfected LNCaP cells.
Graham K; Li W; Williams BR; Fraizer G
Gene Expr; 2006; 13(1):1-14. PubMed ID: 16572586
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expression.
Pinthus JH; Sheffer Y; Nagler A; Fridman E; Mor Y; Genina O; Pines M
J Urol; 2005 Oct; 174(4 Pt 2):1527-31. PubMed ID: 16148645
[TBL] [Abstract] [Full Text] [Related]
17. Par-4 transcriptionally regulates Bcl-2 through a wt1-binding site on the bcl-2 promoter.
Cheema SK; Mishra SK; Rangnekar VM; Tari AM; Kumar R; Lopez-Berestein G
J Biol Chem; 2003 May; 278(22):19995-20005. PubMed ID: 12644474
[TBL] [Abstract] [Full Text] [Related]